HS-10384-matched placebo tablets

DRUG2 trials

Sponsors

Hansoh BioMedical R&D Company

Conditions

Vasomotor Symptoms

Phase 1

Study of HS-10384 in Participants of Chinese Postmenopausal Women

RecruitingNCT06122181

Hansoh BioMedical R&D CompanyVasomotor Symptoms

Start: 2023-11-12End: 2024-09-30Target: 48Updated: 2024-03-13

Phase 2

A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women

Not yet recruitingNCT06393673

Hansoh BioMedical R&D CompanyVasomotor Symptoms

Start: 2024-05-30End: 2025-09-30Target: 195Updated: 2024-05-01